Gerresheimer (ETR:GXI) Stock Price Down 1.7% – Time to Sell?

Shares of Gerresheimer AG (ETR:GXI) fell 1.7% on Thursday . The company traded as low as €76.65 ($83.32) and last traded at €79.70 ($86.63). 201,640 shares were traded during mid-day trading, an increase of 43% from the average session volume of 140,925 shares. The stock had previously closed at €81.10 ($88.15).

Gerresheimer Stock Up 1.4 %

The company has a market cap of $2.71 billion, a PE ratio of 23.34, a price-to-earnings-growth ratio of 0.82 and a beta of 0.94. The business has a fifty day simple moving average of €91.46 and a two-hundred day simple moving average of €97.01. The company has a current ratio of 0.87, a quick ratio of 0.40 and a debt-to-equity ratio of 79.36.

Gerresheimer Company Profile

Gerresheimer AG, together with its subsidiaries, manufactures and sells medicine packaging, drug delivery devices, and solutions in Germany and internationally. It operates through three divisions: Plastics & Devices, Primary Packaging Glass, and Advanced Technologies. The company offers prefillable syringes, plastic and glass packaging solutions, vials, glass cartridges and ampoules, bottles and containers, and glass bottles and jars, as well as caps, closures, applicators, and accessories; development, industrialization and contract manufacturing of drug delivery programs; project and quality management; and drug delivery systems, including inhalers, injection/auto injectors, pen injectors, infusion systems, and inhalation assessment, autoinjector, and other services.